Ferroquine: A Concealed Weapon

Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

Volumn , Issue , 2011, Pages 397-411

  Biot, Christophe ^a   Pradines, Bruno ^b   Dive, Daniel ^a  

^a UNIV LILLE   (France)

^b INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Chloroquine; Ferroquine; Malaria; Mechanism of action; Plasmodium falciparum; Resistance

Indexed keywords

EID: 84884113791     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527633883.ch21     Document Type: Chapter

References (75)

1. Biot, C. and Dive, D. (2010) Metallocenic antimalarials and development of ferroquine, in Medicinal Organometallic Chemistry (eds G. Jaouen and N. Metzler- Nolte), Topics in Organometallic Chemistry, Vol. 32, Springer-Verlag.
2. Desoize, B. (2004) Metals, and metal compounds in cancer treatment. Anticancer Res., 24, 1529-1544.
3. Wilkinson, G., Rosenblum, M., Whiting, M.C.,, and Woodward, R.B. (1952) The structure of iron bis-cyclopentadienyl. J. Am. Chem. Soc., 74, 2125-2126.
4. van Staveren, D.R., and Metzler-Nolte, N. (2004) Bioorganometallic chemistry of ferrocene. Chem. Rev., 104, 5931-5985.
5. Nesmeyanov, A.N., Bogomolova, L.G., Viltcheskaya, V., Palitsyne, N., Andrianova, I.,, and Belozerova, O. (1971) US Patent 119 356.
6. Top, S., Vessiéres, A., Leclercq, G., Quivy, J., Tang, J., Vaissermann, J., Huché, M.,and Jaouen, G. (2003) Synthesis, biochemical properties, and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens, and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormonedependent, and hormone-independent breast cancer cell lines. Chem. Eur. J., 9, 5223-5236.
7. Vessiéres, A., Top, S., Pigeon, P., Hillard, E.A., Boubeker, L., Spera, D.,, and Jaouen, G. (2005) Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro. J. Med. Chem., 48, 3937-3940.
8. Biot, C., Delhaës, L., Maciejewski, L.A., Mortuaire, M., Camus, D., Dive, D.,, and Brocard, J.S. (2000) Synthetic ferrocenic mefloquine, and quinine analogues as potential antimalarials. Eur. J.Med. Chem., 35, 707-714.
9. Paitayatat, S., Tarnchompoo, B., Thebtaranonth, Y.,, and Yuthavong, Y. (1997) Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX. J. Med. Chem., 40, 633-638.
10. Delhaës, L., Biot, C., Berry, L., Maciejewski, L.A., Camus, D., Brocard, J.S.,, and Dive, D. (2000) Novel Ferrocenic artemisinin derivatives: Synthesis, in vitro antimalarial activity, and affinity of binding with Ferroprotoporphyrin IX. Bioorg.Med. Chem., 8, 2739-2745.
11. Baramee, A., Coppin, A., Mortuaire, M., Pelinski, L., Tomavo, S.,, and Brocard, J. (2006) Synthesis, and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii, and Plasmodium falciparum. Bioorg. Med. Chem., 14, 1294-1302.
12. Dive, D., and Biot, C. (2008) Ferrocene conjugates of chloroquine, and other antimalarials: the development of ferroquine, a new antimalarial. ChemMedChem, 3, 383-391.
13. Dubar, F., Anquetin, G., Pradines, B., Dive, D., Khalife, J.,, and Biot, C. (2009) Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/ bioorganometallic approach. J. Med. Chem., 52, 7954-7957.
14. Domarle, O., Blampain, G., Agnaniet, H., Nzadiyabi, T., Lebibi, J., Brocard, J., Maciejewski, L. et al. (1998) In vitro antimalarial activity of a new organometallic analog, ferrocenechloroquine. Antimicrob. Agents Chemother., 42, 540-544.
15. Biot, C., Delhaës, L., Abessolo, H., Domarle, O., Maciejewski, L.A., Mortuaire, M., Delcourt, P., et al. (1999) Novel metallocenic compounds as antimalarials agents. Study of the position of ferrocene in chloroquine. J. Organomet. Chem., 589, 59-65.
16. Biot, C., Daher,W., Jarry, C., Ndiaye, C.H., Pelinski, L., Khalife, J., Fraisse, L., et al. (2006) Probing the role of the covalent linkage of ferrocene into a chloroquine template. J. Med. Chem., 49, 4707-4714.
17. Biot, C., Glorian, G., Maciejewski, L.A., Brocard, J.S., Millet, P., Georges, A.J., Abessolo, H., et al. (1997) Synthesis, and antimalarial activity in vitro, and in vivo of a new ferrocene-chloroquine analogue. J. Med. Chem., 40, 3715-3718.
18. Delhaës, L., Abessolo, H., Biot, C., Deloron, P., Karbwang, J., Mortuaire, M., Maciejewski, L.A., et al. (2001) Ferrochloroquine, a ferrocenyl analogue of chloroquine, retains a potent activity against resistant Plasmodium falciparum in vitro, and P. vinckei in vivo. Parasitol. Res., 87, 239-244.
19. Biot, C., Daher, W., Chavain, N., Fandeur, T., Khalife, J., Dive, D.,, and De Clercq, E. (2006) Design, and synthesis of hydroxyferroquine derivatives with antimalarial, and antiviral activities. J.Med. Chem., 49, 2845-2849.
20. Brocard, J., Lebibi, J.,, and Maciejewski, L. (1995) Patent France 9505532.
21. Brocard, J., Lebibi, J.,, and Maciejewski, L. (1996) Antimalarial organometallic iron complexes. Patent international PCT/FR 96/00721.
22. Chavain, N., Davioud-Charvet, E., Trivelli, X., Mbeki, L., Rottmann, M., Brun, R.,, and Biot, C. (2009) Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors orglutathione depletors via a hydrolyzable amide linker. Bioorg. Med. Chem., 17, 8048-8059.
23. Biot, C., Pradines, B., Sergeant, M.H., Gut, J., Rosenthal, P.J.,, and Chibale, K. (2007) Design, synthesis,, and antimalarial activity of structural chimeras of thiosemicarbazone, and ferroquine analogues. Bioorg. Med. Chem. Lett., 17, 6434-6438.
24. Atteke, C., Ndong, J.N., Aubouy, A., Maciejewski, L., Brocard, J., Lebibi, J.,, and Deloron, P. (2001) In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon. J. Antimicrob. Chemother., 51, 1021-1024.
25. Barends, M., Jaidee, A., Khaohirun, N., Singhasivanon, P.,, and Nosten, F. (2007) In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border. Malar. J., 6, 81.
26. Chim, P., Lim, P., Sem, R., Nhem, S., Maciejewski, L.,, and Fandeur, T. (2004) The in vitro antimalarial activity of ferrochloroquine measured against Cambodian isolates of Plasmodium falciparum. Ann. Trop. Med. Parasitol., 98, 419-424.
27. Kreidenweiss, A., Kremsner, P.G., Dietz, K.,, and Mordmuller, B. (2006) In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum. Am. J. Trop. Med. Hyg., 75, 1178-1181.
28. Pradines, B., Fusai, T., Daries, W., Laloge, V., Rogier, C., Millet, P., Panconi, E., et al. (2001) Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum. J. Antimicrob. Chemother., 48, 179-184.
29. Pradines, B., Tall, A., Rogier, C., Spiegel, A., Mosnier, J.,Marrama, L., Fusai, T., et al. (2002) In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Trop. Med. Int. Health, 7, 265-270.
30. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., Ursos, L.M.B., Sidhu, A.B.S., et al. (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT, and evidence for their role in chloroquine resistance. Mol. Cell, 6, 861-871.
31. Durrand, V., Berry, A., Sem, R., Glaziou, P., Beaudou, J.,, and Fandeur, T. (2004) Variations in the sequence, and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt), and their relationship to chloroquine resistance in vitro. Mol. Biochem. Parasitol., 136, 273-285.
32. Chen, N., Kyle, D.E., Pasay, C., Fowler, E.V., Baker, J., Peters, J.M.,, and Cheng, Q. (2003) pfcrt Allelic types with two novel amino acid mutations in chloroquineresistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother., 47, 3500-3505.
33. Nagesha, H.S., Casey, G.J., Rieckmann, K.H., Fryauff, D.J., Laksana, B.S., Reeder, J.C., Maguire, J.D.,, and Baird, J.K. (2003) New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates. Am. J. Trop. Med. Hyg., 68, 398-402.
34. Johnson, D.J., Fidock, D.A., Mungthin, M., Lakshmanan, V., Sidhu, A.B., Bray, P.G.,, and Ward, S.A. (2004) Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell, 15, 867-877.
35. Cooper, R.A., Ferdig, M.T., Su, X.Z., Ursos, L.M., Mu, J., Nomura, T., Fujioka, H., et al. (2002) Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance, and unique stereospecific quinine, and quinidine responses in Plasmodium falciparum. Mol. Pharmacol., 61, 35-42.
36. Sanchez, C.P., Stein, W.,, and Lanzer, M. (2003) Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry, 42, 9383-9394.
37. Bennett, T.N., Kosar, A.D., Ursos, L.M., Dzekunov, S., Singh Sidhu, A.B., Fidock, D.A.,, and Roepe, P.D. (2004) Drug resistance-associated PfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Mol. Biochem. Parasitol., 133, 99-114.
38. Sidhu, A.B., Verdier-Pinard, D.,, and Fidock, D.A. (2002) Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science, 298, 210-213.
39. Zhang, H., Paguio, M.,, and Roepe, P.D. (2004) The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine. Biochemistry, 43, 8290-8296.
40. Warhurst, D.C., Craig, J.C.,, and Adagu, I.S. (2002) Lysosomes, and drug resistance in malaria. Lancet, 360, 1527-1529.
41. Warhurst, D.C. (2003) Polymorphism in the Plasmodium falciparum chloroquineresistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malar. J., 2, 31.
42. Wilson, C.M., Serrano, A.E., Wasley, A., Bogenschutz, M.P., Shankar, A.H.,, and Wirth, D.F. (1989) Amplification of a gene related to mammalian mdr genes in drugresistant Plasmodium falciparum. Science, 244, 1184-1186.
43. Basco, L.K., de Pecoulas, P.E., Le Bras, J.,, and Wilson, C.M. (1996) Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp. Parasitol., 82, 97-103.
44. Basco, L.K., and Ringwald, P. (1998) Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance, and point mutations in the multidrug resistance 1 (pfmdr1) gene of Plasmodium falciparum. Am. J. Trop. Med. Hyg., 59, 577-581.
45. Povoa, M.M., Adagu, I.S., Oliveira, S.G., Machado, R.L.D., Miles, M.A.,, and Warhurst, D.C. (1998) Pfmdr1 Asn1042Asp, and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant, and -sensitive Brazilian field isolates of Plasmodium falciparum. Exp. Parasitol., 88, 64-68.
46. Pickard, A.L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., Kawamoto, F., et al. (2003) Resistance to antimalarials in Southeast Asia, and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother., 47, 2418-2423.
47. Price, R.N., Cassar, C., Brockman, A., Duraisingh, M., van Vugt, M., White, N.J., Nosten, F.,, and Krishna, N. (1999) The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother., 43, 2943-2949.
48. Duraisingh, M.T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M., andWarhurst, D.C. (2000) The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine, and artemisinin. Mol. Biochem. Parasitol., 108, 13-23.
49. Reed, M.B., Saliba, K.J., Caruana, S.R., Kirk, K.,, and Cowman, A.F. (2000) Pgh1 modulates sensitivity, and resistance to multiple antimalarials in Plasmodium falciparum. Nature, 403, 906-909.
50. Basco, L.K., and Ringwald, P. (2002) Molecular epidemiology of malaria in Cameroon. X. Evaluation of pfmdr1 mutations as genetic markers for resistance to amino alcohols, and artemisinin derivatives. Am. J. Trop. Med. Hyg., 66, 667-671.
51. Mawili-Mboumba, D.P., Kun, J.F.J., Lell, B., Kremsner, P.G.,, and Ntoumi, F. (2002) Pfmdr1 alleles, and response to ultralowdose mefloquine treatment in Gabonese patients. Antimicrob. Agents Chemother., 46, 166-170.
52. Pillai, D.R., Hijar, G., Montoya, I., Marquino, W., Ruebush, T.K., Wrongsrichanalai, C.,, and Kain, K.C. (2003) Lack of prediction of mefloquine, and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru. Am. J. Trop.Med. Hyg., 68, 107-110.
53. Duraisingh, M.T., Roper, C., Walliker, D.,, and Warhurst, D.C. (2000) Increased sensitivity to the antimalarials mefloquineand artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol., 36, 955-961.
54. Ngo, T., Duraisingh, M., Reed, M., Hipgrave, D., Biggs, B.,, and Cowman, A.F. (2003) Analysis of pfcrt, pfmdr1, dhfr,, and dhps mutations, and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before, and after treatment with artemisinin. Am. J. Trop. Med. Hyg., 68, 350-356.
55. Klokouzas, A., Tiffert, T., van Schalkwyk, D., Wu, C.P., van Veen, H.W., Barrand, M.A.,, and Hladky, S.B. (2004) Plasmodium falciparum expresses a multidrug resistance-associated protein. Biochem. Biophys. Res. Commun., 321, 197-201.
56. Henry, M., Briolant, S., Fontaine, A., Mosnier, J., Baret, E., Amalvict, R., Fusai, T., et al. (2008) In vitro activity of ferroquine is independent of polymorphisms in transport proteins genes implicated in quinoline resistance in Plasmodium falciparum. Antimicrob. Agents Chemother., 52, 2755-2759.
57. Mu, J., Ferdig, M.T., Feng, X., Joy, D.A., Duan, J., Furuya, T., Subramanian, G., et al. (2003) Multiple transporters associated with malaria parasite responses to chloroquine, and quinine. Mol. Microbiol., 49, 977-989.
58. Ursing, J., Zakeri, S., Gil, J.P.,, and Bjorkman, A. (2006) Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1, and pfmrp genes of Plasmodium falciparum in Iran. Acta Trop., 97, 352-356.
59. Ferdig, M.T., Cooper, R.A., Mu, J., Deng, B., Joy, D.A., Su, X.Z.,, and Wellems, T.E. (2004) Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol., 52, 985-997.
60. Bennett, T.N., Patel, J., Ferdig, M.T.,, and Roepe, P.D. (2007) Plasmodium falciparum Na({thorn})/H({thorn}) exchanger activity, and quinine resistance. Mol. Biochem. Parasitol., 153, 48-58.
61. Henry, M., Briolant, S., Zettor, A., Pelleau, S., Baragatti, M., Baret, E., Mosnier, J., et al. (2009) Plasmodium falciparum Na{thorn}/H{thorn} exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob. Agents Chemother., 53, 1926-1930.
62. Vinayak, S., Tauqeer Alam, M., Upadhyay, M., Das, M.K., Dev, V., Singh, N., Dash, A.P., et al. (2007) Extensive genetic diversity in the Plasmodium falciparum Na{thorn}/H{thorn} exchanger 1 transporter protein implicated in quinine resistance. Antimicrob. Agents Chemother., 51, 4508-4511.
63. Pradines, B., Pagés, J.-M.,, and Barbe, J. (2005) Chemosensitizers in drug transport mechanisms involved in protozoan resistance. Curr. Drug Targets - Infect. Disorders, 5, 411-431.
64. Henry, M., Alibert, S., Rogier, C., Barbe, J.,, and Pradines, B. (2008) Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr. Top.Med. Chem., 8, 563-578.
65. Alibert Franco, S., Pradines, B., Mahamoud, A., Davin-Regli, A.,, and Pagés, J.-M. (2009) Efflux mechanism, a new target to combat multidrug resistant pathogen. Curr. Med. Chem., 16, 301-317.
66. Macreadie, I.,Ginsburg, H., Siriwaraporn, W.,, and Tilley, L. (2000) Antimalarial drug development, and new targets. Parasitol. Today, 16, 438-444.
67. Biot, C., Taramelli, D., Forbar-Bares, I., Maciejewski, L.A., Boyce, M., Nowogrocki, G., Brocard, J.S., et al. (2005) Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties, and antiplasmodial activity. Mol. Pharm., 2, 185-193.
68. Daher,W., Biot, C., Fandeur, T., Jouin, H., Pelinski, L., Viscogliosi, E., Fraisse, L., et al. (2006) Assessment of P. falciparum resistance to ferroquine in field isolates, and inW2strain under pressure.Malar. J., 5, 11.
69. Yayon, A., Cabantchik, Z.I., andGinsburg, H. (1985) Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl Acad. Sci. USA, 82, 2784-2787.
70. Dorn, A., Vippagunta, S.R., Matile, H., Jacquet, C., Vennerstrom, J.L.,, and Ridley, R.G. (1998) An assessment of drughaematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol., 55, 727-736.
71. Dubar, F., Khalife, J., Brocard, J., Dive, D.,, and Biot, C. (2008) Ferroquine, an ingenious antimalarial drug. Thoughts on the mechanism of action. Molecules, 13, 2900-2907.
72. Delhaes, L., Biot, C., Berry, L., Delcourt, P., Maciejewski, L.A., Camus, D., Brocard, J.S., et al. (2002) Synthesis of ferroquine enantiomers. First investigation of metallocenic, chirality upon antimalarial activity, and cytotoxicity. ChemBioChem, 3, 101-106.
73. Biot, C., Chavain, N., Dubar, F., Pradines, B., Brocard, J., Forfar, I.,, and Dive, D. (2009) Structure-activity relationships of 4-N-substituted ferroquine analogues. Time to re-evaluate the mechanism of action of ferroquine. J. Organomet. Chem., 694, 845-854.
74. Chavain, N., Vezin, H., Dive, D., Touati, N., Paul, J.F., Buisine, E.,, and Biot, C. (2008) Investigation of the redox behavior of the new antimalarial, ferroquine. Mol. Pharmaceutics, 5, 710-716.
75. Fraisse, L.,, and Ter Minassian, D. (2006) Association between ferroquine, and an artemisinine derivative for treating malaria. International Patent PCT/ FR2006/000842.